Pharmasoft
Clinical trials sponsored by Pharmasoft, explained in plain language.
-
New hope for stroke recovery? drug aims to reduce lasting disability
Disease control CompletedThis study tested whether a drug called Mexidol®, when added to standard treatment, could help people recover better after an ischemic stroke. Over 300 patients who had recently suffered a stroke were given either the drug or a placebo for about 10 weeks. Researchers measured if …
Phase: PHASE3 • Sponsor: Pharmasoft • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Brain blood flow drug aims to sharpen thinking and reduce fatigue
Disease control CompletedThis study tested whether a drug called Mexidol could help people with chronic reduced blood flow to the brain. Over 300 participants, aged 40-90 with mild thinking problems, received either the drug or a placebo. Researchers measured changes in memory, thinking skills, fatigue, …
Phase: PHASE3 • Sponsor: Pharmasoft • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
New glaucoma treatment aims to protect vision by boosting eye cell energy
Disease control CompletedThis study tested whether adding a medication called Mexidol to standard glaucoma treatment could help protect the optic nerve and slow vision loss. It involved 80 people with advanced glaucoma whose eye pressure was already under control. Researchers measured changes in the heal…
Phase: PHASE4 • Sponsor: Pharmasoft • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
New drug trial aims to slow vision loss from glaucoma
Disease control CompletedThis study tested different doses of an investigational drug called Mexidol to see if it could help control primary open-angle glaucoma, a leading cause of irreversible vision loss. It involved 102 patients with moderate to severe glaucoma who were already managing their eye pres…
Phase: PHASE2 • Sponsor: Pharmasoft • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC